106 related articles for article (PubMed ID: 7775642)
1. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency.
Fujimoto S; Kubo T; Tanaka H; Miura M; Seino Y
J Clin Endocrinol Metab; 1995 Jun; 80(6):1922-8. PubMed ID: 7775642
[TBL] [Abstract][Full Text] [Related]
2. [Pyridinoline and deoxypyridinoline excretion in urine of healthy children--dependence on age].
Marowska J; Lukaszkiewicz J; Kobylińska M; Matusik H; Tałajko A; Lebiedowski M; Olszaniecka M; Madej M; Lorenc RS
Pol Tyg Lek; 1993 Nov; 48 Suppl 3():39-42. PubMed ID: 8309836
[TBL] [Abstract][Full Text] [Related]
3. Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: normal values and clinical application.
Marowska J; Kobylińska M; Lukaszkiewicz J; Tałajko A; Rymkiewicz-Kluczyńska B; Lorenc RS
Bone; 1996 Dec; 19(6):669-77. PubMed ID: 8968036
[TBL] [Abstract][Full Text] [Related]
4. Urinary pyridinoline and deoxypyridinoline excretion in children.
Shaw NJ; Dutton J; Fraser WD; Smith CS
Clin Endocrinol (Oxf); 1995 Jun; 42(6):607-12. PubMed ID: 7634501
[TBL] [Abstract][Full Text] [Related]
5. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.
Rodríguez-Arnao J; James I; Jabbar A; Trainer PJ; Perrett D; Besser GM; Ross RJ
Clin Endocrinol (Oxf); 1998 Apr; 48(4):455-62. PubMed ID: 9640412
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects.
Ohishi T; Takahashi M; Kawana K; Aoshima H; Hoshino H; Horiuchi K; Kushida K; Inoue T
Clin Invest Med; 1993 Oct; 16(5):319-25. PubMed ID: 8261685
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development.
Mora S; Pitukcheewanont P; Kaufman FR; Nelson JC; Gilsanz V
J Bone Miner Res; 1999 Oct; 14(10):1664-71. PubMed ID: 10491213
[TBL] [Abstract][Full Text] [Related]
8. Urinary pyridinoline and deoxypyridinoline as bone metabolic markers in predicting therapeutic effects of estrogen and alfacalcidol in women with osteoporosis.
Zhan Z; Yamamoto I; Morita R; Miura H
J Bone Miner Metab; 1999; 17(2):113-8. PubMed ID: 10340638
[TBL] [Abstract][Full Text] [Related]
9. [Assay of urinary pyridinoline and deoxypyridinoline as potential markers of the rate of bone resorption: usefulness of urinary pyridinoline and deoxypyridinoline in patients with prostate cancer with bone metastases].
Takeuchi S; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1521-7. PubMed ID: 7990300
[TBL] [Abstract][Full Text] [Related]
10. Urinary levels of pyridinoline and deoxypyridinoline and bone mineral density in children with type 1 diabetes mellitus.
Sav NM; Kendirci M; Akin L; Kurtoglu S
Endocr Res; 2017 Nov; 42(4):281-286. PubMed ID: 28318333
[TBL] [Abstract][Full Text] [Related]
11. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women.
Schlemmer A; Hassager C; Jensen SB; Christiansen C
J Clin Endocrinol Metab; 1992 Mar; 74(3):476-80. PubMed ID: 1740479
[TBL] [Abstract][Full Text] [Related]
12. Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty.
Mora S; Prinster C; Proverbio MC; Bellini A; de Poli SC; Weber G; Abbiati G; Chiumello G
Calcif Tissue Int; 1998 Nov; 63(5):369-74. PubMed ID: 9799819
[TBL] [Abstract][Full Text] [Related]
13. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.
Tobiume H; Kanzaki S; Hida S; Ono T; Moriwake T; Yamauchi S; Tanaka H; Seino Y
J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272
[TBL] [Abstract][Full Text] [Related]
14. Utility of urinary pyridinoline and deoxypyridinoline ratio for diagnosis of osteoarthritis at temporomandibular joint.
Tanimoto K; Ohno S; Imada M; Honda K; Ohno-Nakahara M; Kapila S; Tanne K
J Oral Pathol Med; 2004 Apr; 33(4):218-23. PubMed ID: 15061709
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds.
Husain SM; Mughal Z; Williams G; Ward K; Smith CS; Dutton J; Fraser WD
Arch Dis Child; 1999 Apr; 80(4):370-3. PubMed ID: 10086947
[TBL] [Abstract][Full Text] [Related]
16. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
Body JJ; Delmas PD
J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children.
Rauch F; Schnabel D; Seibel MJ; Remer T; Stabrey A; Michalk D; Schönau E
J Clin Endocrinol Metab; 1995 Apr; 80(4):1295-300. PubMed ID: 7714103
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring markers of bone turnover in multiple myeloma].
Spicka I; Spacek P; Hulejová H; Procházka B; Cieslar P; Chrz M; Válková V; Klener P
Vnitr Lek; 1999 Aug; 45(8):463-7. PubMed ID: 11045145
[TBL] [Abstract][Full Text] [Related]
19. Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis.
Sano M; Kushida K; Takahashi M; Ohishi T; Kawana K; Okada M; Inoue T
Br J Cancer; 1994 Oct; 70(4):701-3. PubMed ID: 7917922
[TBL] [Abstract][Full Text] [Related]
20. Urinary free deoxypyridinoline levels during childhood.
Conti A; Ferrero S; Giambona S; Sartorio A
J Endocrinol Invest; 1998 May; 21(5):318-22. PubMed ID: 9648054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
